Investing Profile

Carol Suh

InvestorVC

Partner at ARCH Venture Partners

Your Intro Paths to Carol Suh

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Carol is a member of

Harvard University Network

720 CONNECTIONS

Yale University Network

344 CONNECTIONS

GSK Network

41 CONNECTIONS

ARCH Venture Partners Network

20 CONNECTIONS

Find Carol Suh on

Current Investing Position

Investment Range

$50K - $150.0M

Sweet Spot

$25.0M

Investments On Record

Current Fund Size

$635.8M

Carol Suh is on these Sector & Stage Rankings

Carol Suh's Investments On Record (2)

Company	StageDateRound Size	Total Raised
HI-Bio	Series BJan 2024$95M Series ANov 2022$120M	$220M
Co-investors: Paul Berns (ARCH Venture Partners)
Orbital Therapeutics	Series AApr 2023$270M SeedSep 2022	$270M
Co-investors: Vineeta Agarwala (Andreessen Horowitz), Kristina Burow (ARCH Venture Partners)

Carol Suh's Experience

R&D Strategy; Innovation Fellow GSKPresent

Senior Associate Consultant Trinity Life SciencesPresent

Business Development and Corporate Strategy Associate; Launch Fellow Magenta TherapeuticsPresent

Board Member HI-Bio: A Biogen CompanyPresent

Partner ARCH Venture PartnersPresent

Co-Founder and Chief Strategy Officer NeumoraPresent

Co-Founder and SVP, Strategy NeumoraPresent

Co-founder, Board Member Orbital TherapeuticsPresent

Carol Suh's Education

Yale University Master of Philosophy (M.Phil.) Genetics

Harvard University Bachelor of Arts (B.A.) Molecular and Cellular Biology

Investors who invest with Carol Suh

Scouts & Angels Affiliated With Carol Suh